These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 9694517
1. Expression of CD45 isoforms lacking exons 7, 8 and 10. Virts E, Barritt D, Raschke WC. Mol Immunol; 1998 Feb; 35(3):167-76. PubMed ID: 9694517 [Abstract] [Full Text] [Related]
2. Developmental expression of CD45 alternate exons in murine T cells. Evidence of additional alternate exon use. Chang HL, Lefrancois L, Zaroukian MH, Esselman WJ. J Immunol; 1991 Sep 01; 147(5):1687-93. PubMed ID: 1831832 [Abstract] [Full Text] [Related]
3. Murine mast cells and monocytes express distinctive sets of CD45 isoforms. Virts E, Barritt D, Siden E, Raschke WC. Mol Immunol; 1997 Sep 01; 34(16-17):1191-7. PubMed ID: 9566766 [Abstract] [Full Text] [Related]
4. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans. Zilch CF, Walker AM, Timón M, Goff LK, Wallace DL, Beverley PC. Eur J Immunol; 1998 Jan 01; 28(1):22-9. PubMed ID: 9485182 [Abstract] [Full Text] [Related]
5. CD45 alternative exon expression in murine and human CD4+ T cell subsets. Rogers PR, Pilapil S, Hayakawa K, Romain PL, Parker DC. J Immunol; 1992 Jun 15; 148(12):4054-65. PubMed ID: 1351092 [Abstract] [Full Text] [Related]
6. Different types of in vivo induced cytolytic T lymphocytes are all LFA-Ihigh and lack CD45 exon 4 (CD45RA) but show distinct CD45RC profiles. Hansson J, Ericsson PO, Widegren B, Dohlsten M, Sjögren HO, Hedlund G. Int Immunol; 1994 Sep 15; 6(9):1375-81. PubMed ID: 7819146 [Abstract] [Full Text] [Related]
7. An analysis of alternatively spliced CD45 mRNA transcripts during T cell maturation in humans. Ratech H, Denning S, Kaufman RE. Cell Immunol; 1997 May 01; 177(2):109-18. PubMed ID: 9178637 [Abstract] [Full Text] [Related]
8. Differential expression of three CD45 alternative structures on murine T cells: exon 6-dependent epitope as a marker for functional heterogeneity of CD4+ T cells. Nishimura H, Hattori S, Abe M, Ueda G, Okamoto H, Tsurui H, Hirose S, Shirai T. Int Immunol; 1992 Aug 01; 4(8):923-30. PubMed ID: 1384687 [Abstract] [Full Text] [Related]
9. Distinct splicing of CD45 mRNA in activated rat gamma delta cytotoxic T lymphocytes. Hansson J, Dohlsten M, Sjögren HO, Hedlund G. Eur J Immunol; 1995 Jan 01; 25(1):75-9. PubMed ID: 7843256 [Abstract] [Full Text] [Related]
10. B-lymphocytes in CLL and NHL differ in the mRNA splicing pattern of the CD45 molecule. Yu Y, Rabinowitz R, Polliack A, Ben-Bassat H, Schlesinger M. Eur J Haematol; 2000 Jun 01; 64(6):376-84. PubMed ID: 10901591 [Abstract] [Full Text] [Related]
11. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation. Lemaire R, Winne A, Sarkissian M, Lafyatis R. Eur J Immunol; 1999 Mar 01; 29(3):823-37. PubMed ID: 10092085 [Abstract] [Full Text] [Related]
12. Identification of novel mRNA isoforms for human DNA polymerase beta. Chyan YJ, Strauss PR, Wood TG, Wilson SH. DNA Cell Biol; 1996 Aug 01; 15(8):653-9. PubMed ID: 8769567 [Abstract] [Full Text] [Related]
13. Identical expression of CD45R isoforms by CD45RC+ 'revertant' memory and CD45RC+ naive CD4 T cells. Hargreaves M, Bell EB. Immunology; 1997 Jul 01; 91(3):323-30. PubMed ID: 9301519 [Abstract] [Full Text] [Related]
14. The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors. Rothstein DM, Saito H, Streuli M, Schlossman SF, Morimoto C. J Biol Chem; 1992 Apr 05; 267(10):7139-47. PubMed ID: 1532394 [Abstract] [Full Text] [Related]
15. A novel CD45 transcript involving the alternative splicing of a new exon is widely distributed in lymphoid tissues. Li D, Brackenridge S, Screaton GR. Hum Immunol; 2004 Dec 05; 65(12):1539-45. PubMed ID: 15603882 [Abstract] [Full Text] [Related]
17. Identification of amino acids at the junction of exons 3 and 7 that are used for the generation of glycosylation-related human CD45RO and CD45RO-like antigen specificities. Pulido R, Schlossman SF, Saito H, Streuli M. J Exp Med; 1994 Mar 01; 179(3):1035-40. PubMed ID: 7509359 [Abstract] [Full Text] [Related]